NYSE:MLSS Milestone Scientific (MLSS) Stock Price, News & Analysis $0.69 +0.03 (+4.55%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$0.65▼$0.7250-Day Range$0.58▼$0.9052-Week Range$0.42▼$1.35Volume266,883 shsAverage Volume182,279 shsMarket Capitalization$49.02 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media About Milestone Scientific Stock (NYSE:MLSS)Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Read More MLSS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MLSS Stock News HeadlinesDecember 26, 2023 | americanbankingnews.comMilestone Scientific (NYSE:MLSS) Coverage Initiated by Analysts at StockNews.comDecember 13, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common StockDecember 31, 2023 | MarketBeat Internal (Ad)New Year's Sale: Get MarketBeat All Access Free For 30 DaysAccess our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscriptionDecember 11, 2023 | msn.comMilestone Scientific prices capital raise of $3.0 million via stock offeringDecember 10, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common StockDecember 8, 2023 | msn.comMilestone Scientific announces proposed public offering of common stockDecember 8, 2023 | finance.yahoo.comMilestone Scientific Inc. Announces Proposed Public Offering of Common StockDecember 8, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation ProceduresDecember 31, 2023 | MarketBeat Internal (Ad)Claim Your $300 MarketBeat Account CreditClick the link below to claim your $300.00 account credit toward MarketBeat All Access. Pay just $99.00 for your 2024 MarketBeat All Access subscription (normally $399.00)November 28, 2023 | msn.comMilestone signs deal to distribute its CompuFlo Epidural System across SpainNovember 28, 2023 | finance.yahoo.comMilestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across SpainNovember 16, 2023 | finance.yahoo.comMilestone Scientific Inc. (AMEX:MLSS) Q3 2023 Earnings Call TranscriptNovember 15, 2023 | finanznachrichten.deMilestone Scientific, Inc.: Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023November 15, 2023 | finance.yahoo.comMilestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023November 14, 2023 | msn.comAsensus Surgical sees gains following equipment saleNovember 10, 2023 | finance.yahoo.comMilestone Scientific Schedules Third Quarter 2023 Financial Results and Business Update Conference CallNovember 9, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New YorkNovember 9, 2023 | finance.yahoo.comMilestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Island Ambulatory Surgery Center in Brooklyn, New YorkSeptember 12, 2023 | finance.yahoo.comMilestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of DirectorsSeptember 12, 2023 | finance.yahoo.comMilestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of DirectorsAugust 15, 2023 | msn.comMilestone Scientific GAAP EPS of -$0.03 misses by $0.01, revenue of $2.9M beats by $0.23MAugust 15, 2023 | finance.yahoo.comMilestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023August 12, 2023 | bizjournals.comSunRail passes 1M annual riders for 1st time since pre-CovidAugust 9, 2023 | finance.yahoo.comMilestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference CallAugust 9, 2023 | finance.yahoo.comMilestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural SystemJuly 22, 2023 | finanznachrichten.deLUCY SCIENTIFIC DISCOVERY INCJune 15, 2023 | msn.comMilestone Scientific: Buy For The $4 Billion Total Addressable MarketSee More Headlines Receive MLSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today12/31/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Surgical appliances & supplies Sub-IndustryN/A SectorMedical Current SymbolNYSE:MLSS CUSIPN/A CIK855683 Webwww.milestonescientific.com Phone(973) 535-2717Fax973-535-2829Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,710,000.00 Net Margins-71.00% Pretax Margin-71.49% Return on Equity-82.04% Return on Assets-58.39% Debt Debt-to-Equity RatioN/A Current Ratio3.04 Quick Ratio2.28 Sales & Book Value Annual Sales$8.81 million Price / Sales5.56 Cash FlowN/A Price / Cash FlowN/A Book Value$0.15 per share Price / Book4.60Miscellaneous Outstanding Shares71,050,000Free Float53,144,000Market Cap$49.02 million OptionableOptionable Beta1.20 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jan Adriaan Haverhals (Age 61)President, CEO & Director Comp: $624.76kMr. Leonard A. Osser (Age 76)Founder, MD of China Operations & Director Mr. Andy Molnar (Age 61)Senior Vice President of Global Sales & Business Development for Dental Keisha HarcumControllerKey CompetitorsEargoNASDAQ:EARReWalk RoboticsNASDAQ:RWLKVicarious SurgicalNYSE:RBOTOceanTech Acquisitions INASDAQ:OTECEnvoy MedicalNASDAQ:COCHView All CompetitorsInstitutional OwnershipCarnegie Capital Asset Management LLCBought 131,812 shares on 10/11/2023Ownership: 0.185%AE Wealth Management LLCBought 27,936 shares on 10/11/2023Ownership: 0.039%View All Institutional Transactions MLSS Stock Analysis - Frequently Asked Questions How have MLSS shares performed in 2023? Milestone Scientific's stock was trading at $0.48 on January 1st, 2023. Since then, MLSS stock has increased by 43.7% and is now trading at $0.6899. View the best growth stocks for 2023 here. How were Milestone Scientific's earnings last quarter? Milestone Scientific Inc. (NYSE:MLSS) issued its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.02) EPS for the quarter. The business had revenue of $2.06 million for the quarter. Milestone Scientific had a negative trailing twelve-month return on equity of 82.04% and a negative net margin of 71.00%. What other stocks do shareholders of Milestone Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and How do I buy shares of Milestone Scientific? Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:MLSS) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Milestone Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.